The type III TGF-b receptor (TbRIII) is a ubiquitous co-receptor for TGF-b superfamily ligands with roles in suppressing cancer progression, in part through suppressing cell motility. Here we demonstrate that TbRIII promotes epithelial cell adhesion to fibronectin in a b-arrestin2 dependent and TGF-b/BMP independent manner by complexing with active integrin a5b1, and mediating b-arrestin2-dependent a5b1 internalization and trafficking to nascent focal adhesions. TbRIII-mediated integrin a5b1 trafficking regulates cell adhesion and fibronectin fibrillogenesis in epithelial cells, as well as a5 localization in breast cancer patients. We further demonstrate that increased TbRIII expression correlates with increased a5 localization at sites of cell-cell adhesion in breast cancer patients, while higher TbRIII expression is a strong predictor of overall survival in breast cancer patients. These data support a novel, clinically relevant role for TbRIII in regulating integrin a5 localization, reveal a novel crosstalk mechanism between the integrin and TGF-b superfamily signaling pathways and identify b-arrestin2 as a regulator of a5b1 trafficking.
INTRODUCTION
Cell-cell and cell-extracellular matrix (ECM) adhesion regulate multiple biological processes including embryonic development, immune recognition, cellular differentiation, migration, proliferation and survival. 1 These adhesion events also play prominent roles in malignant transformation and cancer progression. 1 Cell adhesion is mediated by transmembrane receptors including integrins, 2 immunoglobulin supergene family members 3 and transmembrane proteoglycans. 4 Focal adhesions (FA) are dynamic organelles that mediate cell-ECM adhesion, regulate force transmission and signal in response to receptor engagement with the ECM. 5 Integrin containing FA's form rapidly during cell spreading, which is dependent on integrin engagement with the ECM. 6 Integrins participate in endocytic/ exocytic cycles, 7, 8 which regulate focal adhesion formation, adhesion and motility. 9 However, little is known regarding mechanisms regulating integrin trafficking. During epithelial cell transformation and cancer progression, changes in cell-ECM adhesion response result in changes in integrin conformation and trafficking, which can then directly regulate cell motility, invasion and cell survival. 8 The TGF-b superfamily co-receptor, the type III TGF-b receptor (TbRIII/betaglycan), is a transmembrane proteoglycan that serves as a co-receptor for multiple TGF-b superfamily members. [10] [11] [12] TbRIII has essential, non-redundant roles in regulating signaling through TbRII and TbRI 10, 13, 14 as well as independently of TbRII and TbRI. 15 TbRIII mediates TGF-b signaling independent of its ligand presentation role. 16 In addition, the cell-surface levels of TbRIII and its interacting receptors, TbRII, TbRI, ALK3 and ALK6 are regulated, through the interaction of TbRIII with G-interacting protein-interacting protein, C terminus (GIPC) 17 and barrestin2. 18, 19 We, and others have demonstrated that TbRIII functions as a suppressor of cancer progression in a broad spectrum of human cancers. [20] [21] [22] [23] [24] [25] Mechanistically, TbRIII suppresses cancer progression, at least in part, through regulating random cell migration via b-arrestin2-mediated Cdc42 activation. 26 The ability of TbRIII to suppress cancer progression cannot be explained by its ligand presentation role, as many of these roles, including its ability to inhibit cell migration, occur independently of TGF-b superfamily ligands and TGF-b superfamily signaling. 26 As specific integrins, including integrin a5b1, regulate cell adhesion and random cell migration, 27 here we investigate a role for TbRIII in regulating integrin function.
RESULTS
TbRIII promotes epithelial cell adhesion, focal adhesion formation and integrin signaling during epithelial cell spreading on fibronectin To determine whether TbRIII regulates epithelial cell adhesion to ECM components, we silenced TbRIII with short hairpin interfering RNA's targeting TbRIII (shTbRIII-1 and shTbRIII-2) in the normal mammary epithelial cell line MCF10A, with either scrambled shRNA (shCtl) or non-targeting shRNA (shNTC) as controls ( Figure 1a, Supplementary Figure 1a) . Silencing TbRIII expression via shTbRIII-1 or shTbRIII-2 to TbRIII did not alter the expression of a5 integrin, its substrate, fibronectin (FN), the TbRIII interacting protein b-arrestin2 (Figure 1a Figure 3) , supporting a general role for TbRIII in regulating cell adhesion to FN.
Cell spreading, including formation of focal adhesions (FA), are early events required for efficient cell-ECM adhesion. 28 Using Total Internal Reflection Fluorescence microscopy (TIRFM), we established that shRNA-mediated silencing of TbRIII significantly reduced mean FA length (Figures 1c and d) Integrin clustering during cell spreading results in the rapid recruitment of Focal Adhesion Kinase (FAK) to FA's, FAK phosphorylation (Tyr397) and activation. [29] [30] [31] [32] Consistent with the effects of loss of TbRIII expression on FA formation, reducing TbRIII expression by either shTbRIII-1 or shTbRIII-2 significantly delayed and reduced FAK activation in response to spreading relative to control cells (Figure 1e ). Conversely, increasing TbRIII expression Figure 1 . TbRIII mediates epithelial cell adhesion to fibronectin, regulates focal adhesion formation and FAK activation in response to spreading on FN. MCF10A mammary epithelial cells adenovirally infected with either shTbRIII-1 or shTbRIII-2 to human TbRIII in parallel with controls (shNTC or shCtl) were (a) assessed for cell surface expression of TbRIII by 125 I-TGF-b binding and crosslinking, and for total cellular b-arrestin2, fibronectin and integrin a5 expression, with b-actin as a loading control, and (b) assessed for adhesion to the indicated concentrations of FN for 30 min and the adhesion level plotted (mean ± s.d., *Po0.001). Adhesion assays were performed as described in Methods with BSA as a negative control. (c) MCF10A cells were infected with adenovirus expressing shTbRIII-1, control (shNTC), or TbRIII (HATbRIII), plated on FN coated cover slips for the indicated times, FAs were detected by anti-vinculin antibody against endogenous vinculin using TIRFM. (d) FA length and the mean±s.e.m. were plotted relative to the respective controls (shNTC for shTbRIII; endogenous TbRIII for HA-TbRIII), *Po0.01. Length and intensity of 10 visibly distinct focal adhesions/cell was measured working clockwise from the top of the cell for 10 cells (100 FA measurements per condition). (e) MCF10A-shTbRIII-1 (left panel) or MCF10A-shTbRIII-2 (right panel) with MCF10A-NTC cells as controls were spread on 5 mg/ml FN coated wells for the indicated times and FAK activation (pFAK at Tyr 397), determined by western blot with total FAK as a loading control. Quantitation of the amount of pFAK relative to total FAK is presented below. (f ) MCF10A cells transiently overexpressing either TbRIII or b-arrestin2 were spread on 5 mg/ml FN coated wells for the indicated times and FAK activation (pFAK at Tyr 397), determined by western blot with total FAK as a loading control. Quantitation of the amount of pFAK relative to total FAK is presented below. A full colour version of this figure is available at the Oncogene journal online.
increased the extent of FAK activation upon cell spreading relative to control cells ( Figure 1f ) consistent with increased focal adhesion length and intensity observed upon overexpressing TbRIII (Figures  1c and d) . Taken together, these data support a role for TbRIII in mediating adhesion of epithelial and epithelial-derived cancer cells to FN via regulating nascent FA formation and downstream integrin signaling during cell spreading.
TbRIII controls epithelial cell adhesion to FN via its cytoplasmic domain and independent of TGF-b and BMP To investigate the mechanism by which TbRIII regulates epithelial cell adhesion to FN, we assessed the relative ability of TbRIII or TbRIIIDCyto (lacking the cytoplasmic domain) to rescue shTbRIIImediated decreases in adhesion to FN. While rat TbRIII rescued shTbRIII-mediated decrease in adhesion in MCF10A cells, rat TbRIIIDCyto was unable to do so (Figures 2a and b, Supplementary  Figure 1B) . Similarly, increasing expression of TbRIII increased adhesion to FN, while increasing expression of TbRIIIDCyto was only modestly effective in this regard (Figure 2c ).
To directly assess the contribution of the two major classes of ligands for TbRIII, TGF-b and BMP, we assessed adhesion to FN in the presence of exogenous TGF-b1 or BMP-2. TGF-b1 reduced cell adhesion to FN (Figure 2e ), while BMP-2 had a modest effect on increasing adhesion to FN in MCF10A cells, (Figure 2f ). However, shTbRIII decreased adhesion in the presence of either TGF-b1 or BMP-2 (Figures 2e and f) , albeit to a lesser extent in the presence of TGF-b1. As TbRIII could function to regulate adhesion via sequestration of TGF-b superfamily ligands through production of soluble TbRIII (sTbRIII), we assessed the ability of sTbRIII to regulate the adhesion of MCF10A cells to FN. Treatment with sTbRIII at concentrations which inhibit TGF-b superfamily signaling 26 had no effect on adhesion (Supplementary Figure 4A) . Further, effectively blocking TGF-b signaling with dominant negative TbRII (TbRIID Cyto) (Supplementary Figure 4B) or the ALK-5/TbRI inhibitor, SB431542 or BMP signaling with dominant negative BMPRII (BMPRIIDT, Supplementary Figure 4D) 33,34 had no effect on TbRIII-mediated adhesion to FN (Figure 2d , Supplementary Figure 4B ), suggesting that TbRIII mediates the adhesion of epithelial cells to FN largely independent of its role in regulating TGF-b superfamily signaling.
TbRIII requires active a5b1 to regulate cell adhesion to FN Integrin a5b1 is the main receptor for FN. 35 While shTbRIII decreased adhesion and overexpressing TbRIII increased adhesion of integrin a5b1 positive MCF10A cells to FN (Figure 3a) , increasing or decreasing TbRIII expression did not alter the adhesion of integrin a5b1 null Caco-2 cells 36 to FN (Figure 3a ). To investigate whether integrin a5b1 activation regulated TbRIIImediated adhesion, we utilized K562 leukemia cells, which express predominantly inactive a5b1. 37 Activation of integrin a5b1 with either stimulatory anti-b1 and/or SNAKA51 antibody promoted K562 cell adhesion to FN (Clark et al, 37 Figure 3b). While shTbRIII had no effect on K562 cell adhesion to FN in the absence of a5b1 activation (Figure 3b, Supplementary Figure 4E ), in the context of SNAKA51-induced a5b1 activation and K562 cell adhesion to FN, shTbRIII potently decreased K562 cell adhesion to FN and this effect could be rescued by rat TbRIII (Figure 3b , Supplementary Figure 4E ).
Based on the role of both TbRIII and integrin a5b1 for adhesion to FN, we examined whether TbRIII formed complexes with a5b1. In MCF10A cells endogenous TbRIII and integrin a5 co-localized both at the plasma membrane and in intracellular vesicles ( Figures  3c and d) , while no colocalization was observed in cells lacking TbRIII (Supplementary Figure 5A) . In addition, endogenous integrin a5 and TbRIII co-immunoprecipitated (Figures 3e and f) , shTbRIII (shTbRIII-1 and shTbRIII-2), decreased the association of a5 with TbRIII (Figures 3e and f) , and this could be rescued with expression of full-length rat TbRIII, but to lesser extent by rat TbRIIIDCyto (Figures 3e and f) . Consistent with a role for active integrin a5b1, while a5 did not interact with TbRIII in the absence of a5b1 activation, SNAKA51 strongly induced the interaction of endogenous integrin a5 and TbRIII (Figure 3g ). These data strongly support the preferential association of TbRIII with activated a5b1 via TbRIII's cytoplasmic domain, and a role for a5b1 activation in mediating the effects of TbRIII on adhesion to FN.
TbRIII mediates the trafficking of active integrin a5b1
The ability of epithelial cells to spread on the ECM is dependent on the amount of active and/or total integrin at the cell surface. 38 While TbRIII interacted and co-localized with a5b1 both on the cell surface and internal vesicles, TbRIII did not alter total integrin a5 levels (Figures 1a and 3e and f), suggesting that they associated at the cell surface and cointernalized. 39, 40 Consistent with this hypothesis, primaquine (PMQ), which preserves endosomal integrin complexes, significantly increased the TbRIII and a5b1 interaction (Figures 4a and b) . Further, increasing expression of TbRIII modestly increased vesicular staining of endogenous a5 and significantly increased vesicular staining of endogenous activated a5b1 (Figure 4c ), while shRNA-mediated silencing of TbRIII Figure 5B ), supporting a model in which TbRIII interacts with activated a5b1 at the cell surface and promotes the internalization and trafficking of a5b1 into endocytic vesicles. During early endocytosis, the GTPase Rab5 regulates the passage of cargos from the cell surface/plasma membrane into the early endosome. 41 To establish the early endocytic fate of TbRIII and active a5b1, we stimulated MCF10A cells with SNAKA51 and stimulated internalization for 5 min at 37 1C. b-arrestin2 mediates TbRIII's interaction with a5b1, internalization and TbRIII-dependent adhesion to FN and fibrillogenesis TbRIII internalizes and mediates the internalization of other interacting TGF-b superfamily receptors via the scaffolding protein b-arrestin2, which binds directly to the cytoplasmic domain of TbRIII. 18, 19 Consistent with a role for b-arrestin2 in TbRIII-mediated a5b1 internalization, cell surface labeled active a5b1 co-localized with b-arrestin2 within 5 min of internalization (Supplementary Figure 5C) , and cell surface labeled active a5b1 co-localized with TbRIII and b-arrestin2 in endocytic vesicles 5 min post internalization (Figure 5a ). Further, while over-expression of TbRIII increased a5 and active a5b1 internalization (Supplementary Figure 5D) , over-expression of TbRIII-T841A, which is unable to bind b-arrestin2, 18 was unable to do so. Similarly, while wild type rat TbRIII rescued shTbRIII-mediated decreases in a5 and activated a5b1 internalization, rat TbRIIIT841A was unable to do so ( Figure 5b ).
As the TbRIII/b-arrestin2 interaction had an essential role in TbRIII-mediated regulation of a5b1 internalization, we determined whether the interaction of TbRIII with b-arrestin2 mediates cell Fluorescent microscopy analysis of cell surface, active a5b1 labeled using SNAKA 51 and TbRIII antibody, after allowing internalization at 37 1C for 5 min (T5). Fixed cells were simultaneously stained and imaged for SNAKA 51 (red), TbRIII (green) and DAPI (blue, nucleus). Overlay is presented, with yellow (arrow) indicating colocalization as shown using arrowheads in magnified areas of the boxed regions. Bar ¼ 3.6 mm.
(g,h) Fluorescent confocal microscopy analysis of MCF10A cells, surface labeled with anti-active-a5b1 (SNAKA51) and TbRIII and fixed 5 mins post internalization. Cells were simultaneously labeled for either Rab5 (g), or EEA1 (h) and representative images presented. TbRIII-a5b1 complexes colocalize into Rab5 or EEA1 positive early endosomes as shown in arrowheads in magnified areas of the boxed regions. Endogenous Rab5 colocalizes with TbRIII/a5b1 complexes into early endosomes (solid and empty arrowheads), many of which are located near adhesion sites (empty arrowheads). Bar ¼ 10 mm.
TbRIII/b-arrestin2 regulates a5b1 function K Mythreye et al adhesion to FN. While wild type rat TbRIII rescued the adhesion defect induced by shTbRIII, rat TbRIII-T841A was unable to do so (Figure 5c ). In a reciprocal manner, while increasing TbRIII expression increased adhesion to FN, increasing TbRIII-T841A expression had no effect on adhesion to FN (Supplementary Figure 5E) . Interestingly, while increasing TbRIII expression increased FAK activation (Figure 1f ), increasing expression of b-arrestin2 had a modest effect (Figure 1f) , suggesting that the expression of b-arrestin2 is not rate limiting. Further, silencing TbRIII expression in mouse embryonic fibroblast cells (MEF) from b-arrestin2 À / À mice 42 had no significant effect on adhesion to FN, while silencing TbRIII expression in b-arrestin2 þ / þ MEFs significantly reduced adhesion to FN (Figure 5d ). b-arrestin2 was also required for the interaction of TbRIII with a5, as endogenous a5 and TbRIII co-immunoprecipitated in b-arrestin2 þ / þ MEFs, but not in b-arrestin2 À / À MEFs (Figure 5e ). The contribution of b-arrestin2 to TbRIII's role in adhesion and interaction with a5b1 appears to be specific as silencing TbRIII expression in mouse embryonic fibroblast cells (MEF) from b-arrestin1 À / À mice resulted in a significant reduction in cell adhesion to FN (Supplementary Figure 6A) , demonstrating that b-arrestin1 was not required to mediate TbRIII's role in cell adhesion. In addition, TbRIII was capable of interacting with a5 integrin in b-arrestin1 À / À MEF's (Figure 5e ), indicating that b-arrestin1 was not required to mediate this interaction.
As TbRIII interacts with a5b1 to facilitate FA formation and cellmatrix adhesion to FN, we examined the role of TbRIII in regulating an important aspect of fibronectin function, fibronectin fibrillogenesis. In comparison with shNTC cells, shTbRIII significantly impaired fibronectin fibrillogenesis (Figure 6a ), without altering FN levels (Figure 1a) . Additionally, while rat wild type TbRIII rescued fibrillogenesis, rat TbRIII-T841A was unable to do so (Figure 6a) . Conversely, while overexpressing TbRIII was able to significantly increase fibronectin fibrillogenesis, TbRIII-T841A expression was only partially able to stimulate fibrillogenesis (Supplementary Figure 7A) . These data support a model in which TbRIII-b-arrestin2 mediate interactions with activated a5b1 to regulate its internalization and trafficking, cell adhesion to FN and FN fibrillogenesis.
TbRIII controls the trafficking of active integrin a5b1 to focal adhesions As TbRIII has effects on adhesion, fibrillogenesis and FA formation, and colocalizes in early endocytic vesicles proximal to sites of adhesion, we investigated whether TbRIII regulates the localization TbRIII/b-arrestin2 regulates a5b1 function K Mythreye et al of a5b1 to FA's during cell spreading. Using TIRFM, we established that integrin a5 co-localized with the FA protein, vinculin, with shTbRIII significantly decreasing a5/vinculin co-localization, which was rescued with rat TbRIII (Figures 6b and c) . Consistent with the TIRFM results, a5 or activated a5b1 co-immunoprecipitated vinculin (Figure 6d, Supplementary Figure 7B) , shTbRIII decreased the ability of a5 and vinculin (Supplementary Figure 7B) as well as the ability of active a5b1 and vinculin to interact (Figure 6d ), and these shTbRIII-mediated decreases were rescued by rat TbRIII (Figure 6d, Supplementary Figure 7B) . The ability of shRNAmediated silencing of TbRIII expression to have a greater effect on disrupting activated a5b1-vinculin interactions (Figure 6d ) is consistent with a specific role for TbRIII in mediating trafficking of active a5b1 to FA's, supporting a functional link between TbRIII interacting with activated a5b1 and trafficking a5b1 to sites of adhesion.
TbRIII alters integrin a5 localization in human breast cancer specimen. TbRIII regulates integrin trafficking and integrin a5 localization and incorporation to sites of adhesion ( Figures 5 and 6 ) in vitro. To investigate whether TbRIII regulated integrin a5 expression or localization in the context of human breast cancer we examined a5 expression and localization in a breast cancer tissue array containing 252 breast cancers, where we have demonstrated decreased TbRIII protein expression from normal, to DCIS to lymph node negative invasive breast cancer. 20 Consistent with our in vitro studies, no significant correlation between a5 integrin expression and TbRIII expression at the gene expression level was observed (data not shown). There was also no significant correlation with a5 gene expression and survival in 2 independent gene expression data sets (Figure 7a,  Supplementary Figure 8A ), suggesting that integrin a5 localization may be an important determinant of its function. Consistent with this hypothesis, a5 exhibited distinct localization patterns in normal mammary epithelial cells and cancer cells, either at the lateral surface of cells in ductal regions or cell clusters as described previously, 43 at the basal surface, or diffusely (Supplementary Figure 8E, Figure 7c ). Correlating these data with TbRIII expression in these tissues, 20 we noted marked increases in lateral localization of a5 in invasive breast cancer specimens expressing high TbRIII (Figure 7c and d) . While the proportion of samples with high basal localization also increased with high TbRIII expression, these differences were not statistically significant (Figure 7d) . The data support a model in which TbRIII regulates integrin a5 localization through trafficking of a5b1 to increase lateral a5 localization at sites of cell-cell adhesion in breast cancer clinical specimens.
Loss of TbRIII expression correlates with reduced overall survival in breast cancer patients independent of integrin a5 expression To investigate the functional relationship and overall survival outcome due to TbRIII and a5 expression, we queried the same two data sets, GSE3494 and GSE1456 using median expression value for TbRIII and integrin a5 (IGTA5) to delineate high versus low gene expression. In both datasets, reduced TbRIII gene expression was significantly associated with decreased overall Figure 8B ) supporting our previous findings that low TbRIII expression was significantly associated with a decrease in recurrence-free survival. 20 While there was a trend towards decreased survival between patients with high TbRIII/high a5 and patients with high TbRIII/low a5 this was not statistically significant (Supplementary Figure 8C, D ).
These data demonstrate that while integrin a5 expression levels are not a major determinant of overall survival, TbRIII expression levels are a major driver of overall survival in breast cancer patients. Taken together, these data support a model in which TbRIII suppresses breast cancer progression at least in part through regulating the localization of integrin a5. 20 a5 localization was scored independent of overall levels, as either 0-4 lateral or basal and categorized as low (0-1) and high. [2] [3] [4] Note; diffuse a5 staining in specimen with low TbRIII versus increased lateral localization (arrows) in specimen with high TbRIII. (d) Summary of the quantification of the localization percentages are presented in either Invasive node negative or distant metastasis (Dis. Met)/Invasive Node positive specimen that were combined, *, **Po0.05, 2-tailed Fisher's exact probability.
TbRIII
DISCUSSION
Here we demonstrate that TbRIII, via its cytoplasmic domain, stimulates b-arrestin2 dependent endocytosis and trafficking of activated integrin a5b1 to focal adhesions, promoting focal adhesion formation, cell adhesion to FN and FN fibrillogenesis in epithelial cells. TbRIII also regulates a5 integrin localization to sites of adhesion in breast cancer tissues, with TbRIII expression being a major driver of a5 integrin localization and breast cancer survival. Further, we demonstrate that integrin a5 expression levels are not predictors of overall survival, suggesting that TbRIII-mediated localization of integrin a5 may be an important regulator of disease progression.
TbRIII has been best characterized as a TGF-b superfamily co-receptor. However, neither stimulating TGF-b superfamily signaling with TGF-b1 or BMP-2, nor inhibiting signaling with dominant negative TbRII or BMPRII had an effect on TbRIIImediated cellular adhesion to fibronectin (Figure 2) , supporting a co-receptor function independent role for TbRIII in regulating cell adhesion. While we have previously demonstrated that the TbRIIIb-arrestin2 interaction can regulate the trafficking of interacting TGF-b receptors, TbRII and TbRI/ALK5, 18 as well BMP receptors, ALK3 and ALK6, 19 here we demonstrate a novel interacting partner for TbRIII outside of the TGF-b superfamily-signaling pathway, namely integrin a5b1. The data herein support a model (Figure 8 ) in which TbRIII interacts with activated a5b1 during epithelial cell spreading and/or adhesion via b-arrestin2, enhancing early integrin a5b1 endocytosis, ensuring the recycling of integrin a5b1 to sites of newly forming sites of adhesion and fibrillogenesis (Figure 8) .
Interestingly, while b-arrestin2 was required for TbRIII to stimulate adhesion in mouse embryonic fibroblasts (MEFs), b-arrestin2 ( À / À ) MEFs exhibited a significant increase in adhesion to FN. As b-arrestin2 À / À MEF's induced FAK activation upon cell spreading to the same extent as wild type MEF's (Supplementary Figure 6B) , b-arrestin2 appears to have a complex role in regulating cell adhesion to FN. While b-arrestin2 has been shown to be required for the induction and strengthening of integrin-mediated leukocyte adhesion during CXCR2-driven extravasation 44 and has been hypothesized to play roles as a scaffolding protein for cytoskeletal proteins, 45 data presented here are the first direct demonstration of b-arrestin2 as a regulator of epithelial cell adhesion, focal adhesion formation and integrin a5b1 trafficking. The contribution of b-arrestin2 to cell adhesion, both TbRIII dependent and independent appear to be specific to b-arrestin2, as b-arrestin1 cannot substitute for b-arrestin2 in the context of TbRIII and loss of b-arrestin1 expression had no effect on adhesion to FN (Supplementary Figure 6A) . The TbRIIIindependent contributions of b-arrestin2 to cell adhesion remain to be explored. Consistent with the observed effects of TbRIII on focal adhesion formation, TbRIII is required for integrin-mediated FAK activation, 46 suggesting that TbRIII regulates integrin-mediated insideout signaling, and facilitating integrin engagement with its ligand resulting in activation of FAK. Interestingly, FAK activation has been demonstrated to activate Cdc42 through binding and phosphorylation of the Cdc42 effector N-WASP, 47 suggesting that TbRIII might activate Cdc42, 26 at least in part, through regulating integrin-mediated FAK activation (Figure 8 ). In addition, as loss of TbRIII expression decreases fibrillogenesis in the absence of any significant change in either total integrin a5b1 expression or FN expression, TbRIII may regulate integrin-mediated outside in signaling as well. Whether the TbRIII-mediated regulation of integrin a5b1 internalization, trafficking, and biology extends to other members of the integrin family, and under which contexts, remains to be explored.
Our data on integrin function and trafficking and previously published observations on TbRIII's effects on persistent migration and Cdc42 activation suggest that spatial-temporal localization of active integrin a5b1, as impacted by the TbRIII-b-arrestin2 interaction (Figure 8 ), function to determine the extent and ability of cancer cells to move and invade. The reduced accumulation of a5 at FA's and reduced fibrillogenesis mediated by loss of TbRIII expression would promote rapid FA turnover and faster migration and invasion, consistent with our previously published finding that shTbRIII expression increases cancer cell migration and invasion. 22, 48 Overall, our data suggest a model in which the ability of TbRIII to suppress cancer progression is through the regulation and maintenance of matrix stability and proper accumulation of activated integrin a5b1. Loss of TbRIII expression, as observed in Figure 8 . Model for the TbRIII/ b-arrestin2 dependent integrin a5b1 trafficking and function in epithelial and epithelial-derived cancer cells. At sites of epithelial cell spreading/adhering to FN, TbRIII, via its cytoplasmic domain interaction with the scaffolding protein, b-arrestin2, interacts with Cdc42 26 and active integrin a5b1 that is engaged with fibronectin fibrils. 1 This interaction promotes the Rab5 dependent internalization of the active pool of a5b1.
2 Upon endocytosis, a5b1 is recycled back from TbRIII/b-arrestin2/Rab5 positive vesicles 2 to the cell surface 3 to newly forming focal adhesions at the cell surface or sites of cell-cell adhesion as observed in human tissues. 3 In adherent cells, rapid internalization and recycling of active integrins could play a role in regulating random cell migration of cancer cells as observed previously for TbRIII dependent migration of cancer cells via Cdc42 26 and integrin a5b1 dependent migration. 27 Alternatively, rapid internalization and recycling of active integrins could regulate integrin a5b1 and TbRIII dependent cell-cell adhesion of normal epithelial cells, loss of which could result in disruption of cell polarity and cancer initiation/progression. A full colour version of this figure is available at the Oncogene journal online.
TbRIII/b-arrestin2 regulates a5b1 function K Mythreye et al many cancers, would contribute to the destabilization of the matrix and changes in activated integrin a5 localization, increased motility and invasion and progression of cancer. Consistent with this model, we observed specific effects of TbRIII on a5 localization in breast tumor tissues to sites of cell-cell contact (lateral localization). Recently, increased expression of integrin a5 was found to be associated with ErbB2-positive breast cancers that also resulted in changes in a5 localization 43 possibly due to disruption of cell polarity. Interestingly, while TbRIII expression was strongly associated with increased survival, we found no association of a5 levels with survival in two distinct gene expression data sets, in contrast to a previous study implicating integrin a5 levels as a predictor of overall survival in breast cancer patients. 49 Our data on the role of TbRIII in regulating integrin trafficking and the ECM during cancer progression and TbRIII's role in regulating integrin a5 localization in patient samples suggest that it is not the expression level, but the localization of activated integrin a5 that maybe an important factor in disease progression and outcome. Whether assessment of the localization of integrin a5, or of other integrins and signaling molecules will provide useful prognostic or predictive information in the clinical management of patients is currently under investigation.
MATERIALS AND METHODS

Cell culture, transfection and reagents
Human epithelial cell lines MCF10A, SKOV3, Ovca420 were cultured as described previously. 26, 50 K562 and Caco2 cells were purchased from ATCC. b-arrestin2 mouse embryonic cell lines were a gift from Dr Bob Lefkowitz. 42 All cell lines were grown at 37 1C in a humidified incubator with 5% CO 2 . Antibodies and adenoviral constructs are described in Supplementary Methods. Antibodies to FL-TbRIII were obtained from R&D systems, cell signaling ( catalog #2519) or described previously. 20 Integrin a5 (Catalog #4705), integrin b1 (Catalog #4706), b-arrestin2 (Catalog #3857), FAK (Catalog #3283), total FAK (Catalog #3285), Rab5 (catalog #2143), and EEA1 (catalog #2411) antibodies were obtained from Cell Signaling. The fibronectin antibody (Catalog #SC71114) was from Santa Cruz Technologies and vinculin antibody (Catalog #CP74) was from Calbiochem. BMPRII short (BMPRIIDT) was a kind gift from Liliana Attisano, 33 SNAKA 51 antibody was a kind gift from Martin J Humphries. Human FN, rat-tail collagen and laminin were obtained from Sigma and BD Biosciences.
DNA/Adenoviral constructs, shRNA/siRNA All TbRIII deletion constructs and shRNA constructs have been described previously. 26 All transient transfections and shRNA adenoviral infections were performed as described previously. 22, 26, 51 Adhesion assays 96 well microtiter plates were pre-coated with ECM proteins and saturated with 1% bovine serum albumin. Adherent cells were detached using 5 mM EDTA and resuspended at a cell density of 10-30 000 cells/ml (depending on the cell line) in serum free media with or without the indicated stimuli and plated on the ECM coated microtiter plates. Following adhesion for indicated times, cells were washed in PBS and fixed in 4% paraformaldehyde and then stained with crystal violet for 20 min. The stain was washed, dried and color solubilized using 2% SDS for 20 min. Absorbance was read at 595 nm on the Wallac Victor Counter (PerkinElmer Life Sciences) and values normalized to BSA only controls.
Immunoprecipitation and Western blotting
Cells were lysed in buffer containing 20 mM Hepes pH7.4, 150 mM NaCl, 2 mM EDTA, 10% glycerol, 10 mM NaF and 0.5% NP40 in the presence of protease inhibitors. Cells were lysed in buffer, incubated for 20 min on ice, and then centrifuged at 15 000 g, 20 min at 4 1C. Equivalent amounts of protein were immunoprecipitated overnight with the antibody of interest and immune complexes were recovered on either protein G-Sepharose or protein A-Sepharose (GE Healthcare). Immunoprecipitates were washed four times with lysis buffer, twice with the same buffer without Tween-20, and then separated by SDS-PAGE. Proteins were then transferred to a Hybond-C extra nitrocellulose membrane (Amersham), probed with antibodies of interest, and detected by an enhanced chemiluminescence technique (PerkinElmer).
Fibrillogenesis
Following infection and/or transfection of the cells, cells were seeded onto glass coverslips in a 6 well dish at a cell density of 2 Â 10 5 cells/well and left to adhere for an additional 24-48 h in medium depleted of serum. Cells were then washed with PBS and fixed with 4% paraformaldehyde on ice, permeabilized in 0.1% Triton X-100/PBS on ice for 1 min and incubated with anti-fibronectin antibody for 1 h. Cells were labeled with secondary antibody conjugated to Alexa Fluor 488 for 30 min at room temperature.
Immunofluorescence staining of Formalin fixed paraffin embedded (FFPE) tissue array was performed using Sodium Citrate buffer pH 6.0 with 0.05% Tween 20 in a pressure cooker for antigen retrieval and performed essentially as described previously. 52 Array was stained with integrin a5 (Cell Signaling) antibody overnight at 4 1C followed by Alexa-Fluor conjugated secondary anti-rabbit 488. Array was counterstained for nuclei with DAPI. Images were collected using a Zeiss LSM 510 inverted confocal microscope using either a 40x/1.3 NA oil, 63x/1.4 oil Plan-Apochromat, objective. For scoring purposes, array was scored 'blinded' for TbRIII levels and scored on an epi-flourescent microscope.
Internalization assays
Were performed as described previously 53 and MFI (Mean fluorescence intensity) of the cells, subsequent to stripping un-internalized antibody determined using flow cytometry.
Conventional confocal scanning for colocalization studies and fluorescence microscopy
For immunflourescence analysis of colocalized proteins upon internalization, endogenous integrin a5b1 was cell surface labeled for 30 min at 4 1C using either integrin a5 antibody or 10 mg/ml SNAKA51 antibody, washed and transferred to pre-warmed media and allowed to recover at 37 1C for 5 min to induce endocytosis. Cells were processed for IF and were imaged either by using a Leica SP5 confocal laser-scanning microscope (Leica) or a TE2000 inverted fluorescence microscope. Percent colocalization was determined by determining % pixel overlap using Metamorph software.
TIRF-based microscopy and focal adhesion analysis
Thirty-five mm glass bottom culture dishes (MatTek) coated with 5 mg/mL fibronectin (Calbiochem) were used to image fixed cells on a Leica AM TIRF microscope. Length and intensity of 10 visibly distinct focal adhesions/cell was measured working clockwise from the top of the cell for 10 cells (100 FA measurements per condition). Intensity of a line drawn through the dark background was subtracted to account for differences in background intensity.
Gene expression analysis
Clinical data, including overall survival, and raw expression data (.CEL) files were acquired from NCBI Gene Expression Omnibus (GEO) for GSE3494 (n ¼ 251) and GSE1456 (n ¼ 159). Data was MAS5 normalized using Affymetrix Expression Console (Version 1.0). The Affymetrix HG-U133A plus 2 probe set annotation file (release 29) was acquired from the Affymetrix website and probe sets identified for TbRIII (204731_at) and IGTA5 (201389_at). The median expression value for TGFbR3 and IGTA5 was used to delineate high versus low gene expression. A Kaplan-Meier survival curve was generated using GraphPad Prism 4.0.
Statistical analysis
Significance of results was assessed using two-tailed Student's t-test unless otherwise indicated. *P-values are as indicated in the Figures and P values o0.05 were considered significant. Error bars represent either mean ± s.e. or mean ± s.d. as indicated. Data are representative of a minimum of three independent experiments, unless otherwise indicated.
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